Overview
Primary squamous cell carcinoma (SCC) of the glottis is a significant malignancy affecting the larynx, predominantly linked to environmental factors, particularly cigarette smoke (CS) exposure. This condition poses substantial clinical challenges, especially given the increasing prevalence in elderly populations. Understanding the pathophysiology, epidemiology, and effective management strategies is crucial for optimizing patient outcomes. This guideline synthesizes current evidence to provide clinicians with a comprehensive approach to diagnosing, treating, and managing patients with primary glottic SCC.
Pathophysiology
The development of primary squamous cell carcinoma of the glottis is intricately linked to chronic exposure to cigarette smoke, a potent carcinogen cocktail. Studies in murine models have demonstrated that CS exposure induces epithelial hyperplasia in vocal folds, disrupting cell junctions and altering mucus production [PMID:33864646]. These changes compromise the protective barriers of the larynx, facilitating the accumulation of carcinogens and promoting cellular mutations. In clinical practice, these mechanistic insights underscore the critical importance of smoking cessation as a preventive measure. Beyond direct carcinogen exposure, CS may also impair local immune responses and disrupt normal tissue repair mechanisms, further contributing to the progression of laryngeal malignancies.
Epidemiology
The epidemiology of primary glottic SCC reflects significant public health concerns, particularly due to high rates of cigarette smoke exposure. With over 40 million adults in many populations continuing to smoke, the risk of developing laryngeal diseases, including SCC, remains elevated [PMID:33864646]. Demographic shifts towards an aging population have also heightened the clinical relevance of managing laryngeal cancer in elderly patients, who may present with unique challenges related to comorbidities and treatment tolerance. A retrospective study focusing on elderly patients (≥70 years) undergoing transoral laser microsurgery (TLM) highlighted the feasibility and favorable outcomes of surgical interventions in this demographic, with low complication rates and high survival rates [PMID:33834885]. This evidence supports the need for tailored, evidence-based management strategies that consider both age-related factors and the aggressive nature of laryngeal cancer.
Diagnosis
Diagnosis of primary glottic SCC typically involves a combination of clinical evaluation, imaging, and histopathological confirmation. Patients often present with symptoms such as hoarseness, dysphonia, or throat pain, prompting further investigation. Flexible laryngoscopy is a cornerstone diagnostic tool, allowing direct visualization of the vocal cords and facilitating biopsy sampling when suspicious lesions are identified. Imaging studies, including computed tomography (CT) and magnetic resonance imaging (MRI), are crucial for staging the extent of disease and assessing potential invasion into surrounding structures. Histopathological examination of biopsy specimens confirms the diagnosis and helps determine the grade and stage of the carcinoma, guiding subsequent treatment decisions. While specific diagnostic protocols are not extensively detailed in the provided evidence, these general principles form the backbone of clinical practice in diagnosing glottic SCC.
Management
Surgical Management
Transoral laser microsurgery (TLM) has emerged as a minimally invasive yet effective surgical approach for treating primary glottic SCC, particularly in elderly patients. A retrospective study of 93 elderly patients (≥70 years) undergoing TLM reported no treatment-related deaths, minimal intensive care unit admissions, and low complication rates, with most procedures conducted as day cases or short-stay admissions [PMID:33834885]. The high 5-year disease-specific survival rate (>90%) underscores the efficacy and safety of TLM in this population. Surgeons often employ conservative techniques to preserve laryngeal function while achieving oncologic control, aligning with the observed recurrence rates comparable to younger patients [PMID:33834885].
Radiotherapy
Radical radiotherapy remains a cornerstone in the management of primary glottic SCC, especially for patients who are not surgical candidates or prefer non-invasive approaches. A study involving 861 patients demonstrated that primary radical radiotherapy achieved tumor control in 83% of cases, with 68% of patients avoiding laryngectomy [PMID:12142089]. For smaller tumors (T1a, T1b, T2), survival rates were notably higher, ranging from 95% to 83% at 5 years, respectively [PMID:12142089]. These outcomes highlight the importance of precise tumor staging and tailored radiotherapy protocols to maximize local control and preserve organ function.
Salvage Therapy
For patients experiencing persistent or recurrent disease, salvage interventions play a critical role in managing treatment failures. Studies indicate that curative salvage attempts, often involving surgery or further radiotherapy, are successful in approximately 70% of cases [PMID:12142089]. This underscores the necessity of close surveillance and prompt intervention in managing recurrent glottic SCC, emphasizing the multidisciplinary approach required to tailor salvage strategies effectively.
Complications
Despite advancements in treatment modalities, complications remain a concern, particularly in elderly patients. In the context of TLM, complications such as dysphagia are relatively common but manageable. A study noted that only one elderly patient required hospital readmission due to dysphagia, necessitating an altered diet, while no patients required tracheostomy or tube feeding [PMID:33834885]. However, long-term surveillance is essential due to the risk of developing new primary malignancies; among 718 patients cured of glottic carcinoma, 204 developed subsequent malignancies, highlighting the need for vigilant follow-up [PMID:12142089]. Clinicians should monitor for both immediate postoperative complications and long-term sequelae, integrating supportive care measures to enhance patient quality of life.
Prognosis & Follow-up
The prognosis for patients with primary glottic SCC varies based on tumor stage, patient age, and treatment modality. Ten-year follow-up data from various studies indicate that while recurrence can occur within 5 years, effective management through further TLM, radiotherapy, or salvage laryngectomy maintains high survival rates [PMID:33834885]. Specifically, patients treated with curative intent radiotherapy exhibit a 5-year disease-specific survival rate of 86% and overall survival rates of 66% [PMID:12142089]. Smaller tumors generally confer better prognoses, with survival rates exceeding 90% for early-stage disease [PMID:12142089]. Regular follow-up, including periodic laryngoscopy and imaging, is crucial for early detection of recurrence or new primary tumors, ensuring timely intervention and optimal outcomes.
Key Recommendations
These recommendations aim to guide clinicians in providing comprehensive care for patients diagnosed with primary squamous cell carcinoma of the glottis, balancing efficacy with patient-centered outcomes.
References
1 Erickson-DiRenzo E, Easwaran M, Martinez JD, Dewan K, Sung CK. Mainstream Cigarette Smoke Impacts the Mouse Vocal Fold Epithelium and Mucus Barrier. The Laryngoscope 2021. link 2 Jones H, Ross E, Jose J. TLM Outcomes in Elderly Patients with Glottic Pre-Malignancy and Early Malignancy; A 12-Year Retrospective Study. The Annals of otology, rhinology, and laryngology 2021. link 3 Johansen LV, Grau C, Overgaard J. Glottic carcinoma--patterns of failure and salvage treatment after curative radiotherapy in 861 consecutive patients. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2002. link00118-4)